Latham & Watkins LLP represented VistaGen in the transaction. VistaGen Therapeutics, Inc. (VistaGen) closed its underwritten public offering of 63 million shares of its common stock,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now